Zheng, Z., Liu, T., Zhang, Y., Zhu, H., Fang, L. (2026). Cost-effectiveness analysis of toripalimab and bevacizumab versus sorafenib for advanced hepatocellular carcinoma in China. Scientific Reports. https://doi.org/10.1038/s41598-026-50815-5